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Abstract
Background—The New Hampshire Birth Conditions Program (NHBCP) is a population-based, 
active case ascertainment surveillance system that monitors the occurrence of 45 birth defects 
across the state. A 2008 law requires a new opt-out procedure whereby legal guardians can choose 
whether or not to have identifiable information retained in the NHBCP database. The purpose of 
this study was to determine the effects of implementing this opt-out legislation on data collection 
and surveillance of birth defects by the NHBCP.
Methods—Using surveillance data collected following implementation of the opt out legislation 
for the period January 1, 2007, through December 31, 2009, 2 opt-out groups were created: the 
identifiable information retained (IIR) group, consisting of families who did not choose to opt out, 
and the de-identified information retained group (DIIR), consisting of those who either chose to 
opt out or were treated as opt-out birth defect cases because their opt-out package was 
undeliverable. Descriptive statistics were calculated for each group, and chi-square or Fisher’s 
exact tests were used to compare the proportion of select sociodemographic and medical 
characteristics between the 2 opt-out groups.
Results—Of 776 infants, 120 (15.5%) fell into the DIIR group. Differences were observed by 
race/ethnicity (among non-Hispanic whites, 15% were in the DIIR group and among Hispanics, 
33% were in the DIIR group; p=0.01) and by maternal age (among women 30–34 years of age, 
11% were in the DIIR group, and among those 25 years of age or younger, 22% were in the DIIR 
group; p=0.05). Birth outcomes, payer source, county of residence, and common birth defect 
diagnoses did not differ between the opt-out groups.
Conclusion—This study demonstrated that there were significant differences in race/ethnicity 
and maternal age between parents who had de-identified information included in the NHBCP 
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compared with those who did not choose to opt out. Although the surveillance of birth defects is 
not affected, the opportunities for certain types of research will be limited.
Keywords
opt-out; birth defects; surveillance; congenital malformations
Introduction
Surveillance of birth defects is important for identifying patterns in prevalence and potential 
risk factors. Birth defects occur among 3% of births, and are one of the leading causes of 
infant mortality in the United States.1 The causes of 65%–80% of birth defects are 
unknown2; however, certain risk factors have been linked with abnormal fetal 
development.3 Using data from birth defects surveillance systems, research studies may 
identify these risk factors, resulting in preventative action to decrease the occurrence of 
specific birth defects (for example, using folic acid supplementation to reduce the incidence 
of neural tube defects).3,4 Birth defect surveillance systems have been essential in 
comparing the prevalence of neural tube defects before and after fortification of enriched 
cereal grains with folic acid in the United States, and in identifying ethnic and racial 
disparities, resulting in targeted preconception folic acid awareness campaigns.4
In 2003, the New Hampshire Birth Conditions Program (NHBCP) was created. The NHBCP 
is a population-based, active case ascertainment surveillance system that monitors the 
occurrence of 45 birth defects among all newborns, stillborns, terminated fetuses (no 
gestational age limit), and infants up to 2 years of age. Although strict procedures are in 
place for protecting privacy and data confidentiality, a 2008 law (New Hampshire RSA 
141:J) was passed requiring implementation of a new opt-out procedure that allows 
individuals the option to have identifiable information removed from the NHBCP database. 
This law applies to data collected from January 1, 2007 onwards. The purpose of this study 
was to assess the effects of the implementation of the opt-out legislation on data collection 
by the NHBCP and the surveillance of birth defects in New Hampshire.
Methods
Data Source
The NHBCP collects data from health care providers, health care facilities, clinics, 
laboratories, medical records departments, and state offices and agencies. Birth hospitals are 
visited at least annually for medical chart abstraction; cases confirmed through fetal 
pathology reports or clinical assessments also are included. The NHBCP birth defects list is 
based on guidance from the National Birth Defects Prevention Network and the Centers for 
Disease Control and Prevention (CDC). The NHBCP includes birth defect cases who meet 
the all of the following criteria: (1) offspring of a New Hampshire resident at time of birth; 
and (2) stillborn fetus, terminated fetus, or liveborn infant for whom a diagnosis is made no 
later than 2 years of age; and (3) infants or fetuses found by clinical assessment or autopsy 
to have a structural condition that meets the diagnostic criteria for a reportable birth 
condition.
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As indicated in the legislation, the NHBCP is required to notify in writing the legal guardian 
or guardians of each individual with a birth defect diagnosis before retaining any identifiable 
information. During case abstraction, all information is collected on a paper form. Before 
information is entered into the electronic NHBCP database, and within a week of case 
abstraction, opt-out packages are mailed. If no response is obtained within 60 days of 
providing the notice, the NHBCP may retain identifiable information and enter all 
information into the database; however, the legal guardians can elect at any time to not 
participate in the NHBCP (Figure 1). If the mailed package is undeliverable and returned to 
sender, the birth defect case is retained; however, no identifiable information is entered into 
the NHBCP database (Figure 1). If legal guardians choose to opt-out, they are required to 
return the signed opt out form requesting their identifiable information not be retained.
In addition to the birth defect diagnoses of offspring, information on other pregnancy 
outcomes, medical history, and demographics, as well as personal information, are collected. 
This information is collected from medical records and entered into the NHBCP database. 
The NHBCP obtains race/ethnicity data from birth certificates and uses the mother’s 
selection as a proxy for the baby. If the mother’s and father’s race differ, “more than one 
race listed” is selected. Personal identifiers and birth outcome data are also linked to birth 
certificate data for biannual data field checks to ensure accuracy and review missing fields 
such as maternal race and ethnicity, gestational age, maternal age, and paternal age. For 
those who choose to opt out or whose opt-out package is undeliverable, all information is 
retained within the NHBCP database with the exception of identifiable information such as 
names, street address, and day and month of birth.
Analytic Methods
Because the purpose of this study was to evaluate the effects of the opt-out procedure, 
NHBCP data following implementation of the opt-out legislation for the period January 1, 
2007, through December 31, 2009, were used to create 2 opt-out groups for this time period: 
the identifiable information retained (IIR) group, consisting of birth defect cases for whom 
the legal guardian(s) did not choose to opt out, and the de-identifiable information retained 
(DIIR) group, consisting of those birth defect cases for whom their legal guardian(s) chose 
to opt out or who were treated as having opted out because the mailed opt-out package could 
not be delivered.
Data regarding sociodemographic and medical characteristics, including infant race/
ethnicity, maternal age at delivery, infant year of birth, birth outcome, payer source, county 
of residence, and birth defect diagnosis were assessed. Descriptive statistics were calculated 
for each opt-out group, and chi-square tests, or Fisher’s exact tests, when the expected cell 
counts were less than 5, were used to compare characteristics between the 2 groups. 
Statistical significance was assessed at p < 0.05 using SAS version 9.2 (SAS Institute Inc., 
Cary, North Carolina).
Results
For the period 2007–2009, 776 infants were identified for inclusion by the NHBCP, of 
whom 120 (15.5%) fell into the DIIR group. Among the mothers of Hispanic and “other” 
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ethnicities, larger proportions (33% and 29%, respectively) were in the DIIR group when 
compared to non-Hispanic white mothers at 15% (Table 1). For the different age categories, 
the largest proportion of mothers who were in the DIIR group were those younger than 25 
years of age (Table 1). No significant differences by infant year of birth were observed; 
however, the higher number of birth defect cases among the DIIR group during the initial 
implementation of the law most likely was due to delayed mailings and, hence, a higher 
proportion of undeliverable opt-out packages (Table 1). Although there were no statistically 
significant differences by payer source, of those with private insurance, only 12% were in 
the DIIR group; whereas, of those with Medicaid or who self-paid, 20% and 19% 
(respectively) were in the DIIR group (Table 1). No substantial differences by birth 
outcome, county of residence (Table 1), or birth defect diagnoses (Table 2) were observed.
Discussion
Results from this study demonstrated that certain factors could be associated with a family’s 
willingness to have their identifiable information included in a birth defect surveillance 
system. Key differences in some sociodemographic characteristics existed between the IIR 
group, consisting of families who did not choose to opt out of the NHBCP surveillance 
system, and the DIIR group, consisting of those who either did choose to opt out or were 
treated as opt-out birth defect cases because the mailed opt-out package was not deliverable. 
There were significant differences in infant race/ethnicity and maternal age at delivery, 
suggesting that there might have been socioeconomic differences influencing the decision to 
opt out, or that younger mothers and those of Hispanic ethnicity might have been more 
transient and harder to reach via mail. In a study that examined characteristics between 
mothers who had a baby born with a birth defect who either consented or did not consent to 
follow-up, significant differences were also observed by race and maternal age; however, 
these differences disappeared after adjustment for perinatal mortality.5 Although not 
statistically significant, in the current study, the differences observed by payer source, a 
proxy for socioeconomic status, also suggests that there might have been notable 
socioeconomic differences between the IIR and DIIR groups, as a greater proportion of 
those with Medicaid or who self-paid were more likely to opt out or have the opt-out 
package be undeliverable.
Within the DIIR group, we were not able to distinguish between the parents who chose to 
have their identifiable information removed from those parents who were considered to have 
opted out due to an undeliverable mail package as the reason why a case is in the DIIR 
group is not included in the NHBCP database. As a result, we were not able to assess 
differences between these 2 subgroups. Fortunately, the NHBCP is required to remove only 
identifiable information for the DIIR group regardless of whether the parent chose to opt out 
or the mail was undeliverable; if all data were to be removed for true opt-outs, for those 
classified as having opted out because of undeliverable mail, or for both of these sub-groups, 
there would be a considerable impact on accurate surveillance as prevalence rates for 
specific birth defects would be affected. Incomplete case inclusion in a given region would 
result in distorted prevalence estimates, resulting, in turn, in underestimation of the health 
care service needs of infants born with specific birth conditions.3 Additionally, differences 
in birth defect occurrence between the 2 opt-out groups could affect the accuracy and 
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usefulness of the birth defect surveillance system; however, there did not appear to be 
substantial differences in the proportion of specific birth defects between the 2 groups. As it 
stands, the lack of identifiable information in the NHBCP will affect research studies if 
long-term follow-up is required, or if geospatial analysis is to be conducted for birth defect 
cluster analysis.6 Fortunately, researchers are still able to link infant records with maternal 
and paternal records; therefore, most risk factors for birth defects can be assessed in future 
studies.3
Public health surveillance is critical for monitoring diseases or conditions for their 
prevalence, potential risk factors, and health service requirements.7 To ensure appropriate 
evidence-based activities are created, complete and accurate surveillance data are 
necessary.8 Birth defects surveillance systems have access to data sources containing 
individual, health-related information under public health authority; however, as data 
protection and security concerns are increasing, state legislatures can mandate additional 
reporting guidelines and procedures.6,8 Privacy concerns and their effects on accurate 
surveillance are national issues, and not unique to New Hampshire.7 As is the case in New 
Hampshire, if opt-out procedures are mandated by law, it will be critical to improve these 
procedures to ensure surveillance is maximized for optimal public health benefit.
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Figure 1. 
Flowchart Describing the Inclusion and Exclusion of Identifiable Information in the New 
Hampshire Birth Conditions Program (NHBCP) Depending on Opt-out Status
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Table 2
Birth Defectsa in the NHBCP from 2007–2009 in the Identifiable Information Retained (IIR) Groupb and the 
De-identified Information Retained (DIIR) Groupc
Birth Defect
IIR Group (n=656) DIIR Group (n=120)
n % n %
Spina bifida 7 100 0 0
Microcephaly 12 80 3 20
Macrotia 5 83 1 17
Tetralogy of Fallot 10 83 2 17
Ventricular septal defects 38 84 7 16
Patent foramen ovale 14 93 1 7
Pulmonary valve stenosis 10 83 2 17
Hypoplastic left heart syndrome 9 100 0 0
Pulmonary atresia 10 91 1 9
Coarctation of the aorta 4 80 1 20
Orofacial clefts 34 87 5 13
Pyloric stenosis 79 82 17 18
Intestinal atresia 8 80 2 20
Intestinal aganglionosis 6 100 0 0
Hypospadias 126 82 27 18
Unilateral renal agenesis 16 76 5 24
Hydronephrosis 75 83 15 17
Hip dislocation 20 87 3 13
Limb deficiency 7 78 2 22
Diaphragmatic hernia 7 100 0 0
Gastroschisis 6 75 2 25
Trisomy 21 20 83 4 17
Multiple defects 95 86 16 14
aOnly displaying birth defects that had 5 or more cases, by infant.
b
Identifiable information retained (IIR) group consists of parents that did not choose to opt out.
c
De-identified information retained (DIIR) group consists of parents that either chose to opt out, or were treated as an opt-out case since the mailed 
opt-out package was not delivered.
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